NeuMoDx Molecular Competitors, Revenue, Alternatives and Pricing
Claim your profile
Overview
Industry Ranking
Estimated Revenue & Financials
- NeuMoDx Molecular's estimated annual revenue is currently $18.6M per year.
- NeuMoDx Molecular received $20.0M in venture funding in May 2016.
- NeuMoDx Molecular's estimated revenue per employee is $251,000
Employee Data
- NeuMoDx Molecular has 74 Employees.
- NeuMoDx Molecular grew their employee count by 28% last year.
- NeuMoDx Molecular currently has 1 job openings.
NeuMoDx Molecular Competitors
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Pricing |
|---|---|---|---|---|---|
| $14.8M | 59 | N/A | N/A | N/A | |
| N/A | 202 | N/A | N/A | N/A | |
| $20.8M | 83 | 4% | N/A | N/A | |
| $43.4M | 173 | N/A | N/A | N/A | |
| $7M | 28 | N/A | N/A | N/A | |
| $6.3M | 25 | N/A | N/A | N/A | |
| $16.3M | 65 | 8% | N/A | N/A | |
| $26.4M | 105 | 4% | N/A | N/A | |
| $62.8M | 250 | 6% | N/A | N/A | |
| $11.3M | 45 | N/A | N/A | N/A |
Missing a competitor? Contribute!?
Submit
What Is NeuMoDx Molecular?
74
Number of Employees
$18.6M
Revenue (est)
1
Current Jobs
28%
Employee Growth %
N/A
Total Funding
N/A
Valuation
N/A
Accelerator
B2B
Type
Executive Contacts
| Name | Title | |
|---|---|---|
| Jeff Williams | CEO/Chairman | Email Available |
| Sundu Brahmasandra | President and COO, NeuMoDx Molecular | Email Available |
| Jeff Williams | Chairman and CEO | Email Available |
| Manjeet Sandhu | Business Development Manager | Email Available |
| John Neisser | Business Development Manager at NeuMoDx Molecular | Email Available |
| Dawn Winder | Sr. Director of Quality | Email Available |
| Dan Harma | Chief Commercial Officer | Email Available |
| Marlo Ives | Reagent Production Manager | Email Available |
| Dominick Pennella | Director Of Customer Services | Email Available |
| Jennifer Ruth | Clinical Affairs Manager | Email Available |
NeuMoDx Molecular News
08/12/2019 - NeuMoDx Files Defense, Counterclaims in BD Patent ...
NEW YORK – NeuMoDx has filed a response with the District of ... by Becton Dickinson that the molecular diagnostics developer infringed on ...
09/05/2019 - Global Biochips Market Overview 2019: Market Value ...
1.1.8.2.1.1 Lab-on-a-chip and Molecular Biology ... Cancer Therapy; QIAGEN NV Selects NeuMoDx Molecular, Inc for CE-IVD Assays Purchase ...
04/11/2019 - QIAGEN and NeuMoDx expand assay menu for their next ...
BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today announced an expansion ...
NeuMoDx Molecular Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-03-28 | $10.5M | Undisclosed | Article | |
| 2014-04-02 | $21.0M | B | Pfizer Ventures | Article |
| 2016-05-03 | $20.0M | Undisclosed | Article |